A study of a Finnish radical prostatectomy series suggested that the association between statin use and risk of recurrence could be modified by tumour Ki67 and ERG expression, with a lower risk of recurrence among men with higher Ki67 proliferative index, and without ERG expression, among many potential effect modifiers explored [51]. Here, MKI67 is linked to neoplasm.